WAS
NVCR icon

Winch Advisory Services’s NovoCure NVCR Stock Holding History

Winch Advisory Services’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-300
Closed -$6K – 318
2017
Q4 		$6K Sell
300
-300
-50% -$5.78K ﹤0.01% 210
2017
Q3 		$12K Buy
+600
New +$11.8K 0.01% 159

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Winch Advisory Services's NVCR Position: Q1 2018 in Review

Winch Advisory Services sold out of NovoCure (NVCR) in Q1 2018, closing a stake of 300 shares — an estimated $6K sold.

Winch Advisory Services first reported a position in NVCR in Q3 2017 and held it in 2 quarters. The position peaked at $12K in Q3 2017. 129 funds tracked by Wall St. Rank hold NVCR as of Q1 2018.

  • Winch Advisory Services reported no remaining NovoCure position as of Q1 2018 after selling out during the quarter.
  • Winch Advisory Services sold 300 NovoCure shares in Q1 2018, an estimated $6K.
  • Winch Advisory Services first reported a position in NovoCure in Q3 2017 and held it in 2 quarters.
  • Winch Advisory Services's NovoCure position peaked at $12K in Q3 2017.
  • 129 funds tracked by Wall St. Rank held NovoCure as of Q1 2018.

Based on Winch Advisory Services's 13F filing for Q1 2018, filed 11 May 2018.